<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Zwam, M. van</title>
    <link>http://repub.eur.nl/res/aut/25882/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo (Article)</title>
      <link>http://repub.eur.nl/res/pub/26691/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>During MS, phagocytosing myelin-containing macrophages arise and lie in close proximity to T cells. To date, it has not been addressed whether these myelinladen macrophages have the capacity to present antigens to T cells and whether this contributes to inflammation in disease. We demonstrate that in vitro-generated human and mouse myelin-laden macrophages expressed MHC class I and II and costimulatory molecules and are thus well equipped for antigen presentation.uman myelin-laden macrophages exhibited normal endocytosis of particulate and soluble antigens. In addition, human myelin-laden macrophages elicited active T cell proliferation of nai{dotless}̈ve as well as memory T cells. Furthermore, mouse myelin-laden macrophages induced primary antigen-specific CD4+T cell proliferation in vivo but transiently diminished IFN-γ release. Functionally, MOG peptide-loaded myelin-laden mouse macrophages modestly but significantly reduced the severity of MOG peptide-induced EAE. These data show that myelin uptake results in the induction of a population of macrophages that retains antigen-presenting capacity and limits autoimmune-mediated disease. </description>
    </item> <item>
      <title>Myelin ingestion by macrophages promotes their motility and capacity to recruit myeloid cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/21099/</link>
      <pubDate>2010-08-01T00:00:00Z</pubDate>
      <description>Myelin-laden macrophages reside within the CNS, the CSF and in the CNS-draining lymph nodes during MS and EAE, suggesting migration of these macrophages between these compartments and interaction with other cells. Since chemokines and their receptors are pivotal for leukocyte trafficking, we addressed whether myelin ingestion affects chemotaxis of mouse macrophages in vitro. Myelin ingestion enhanced expression of CCR7 and CXCR3 on macrophages and migration towards CCL21 and CXCL10. Furthermore, myelin-laden macrophages released chemoattractants resulting in enhanced migration of myeloid cells in vitro. Our data demonstrate that myelin-laden macrophages have increased motility and suggest trafficking between anatomical compartments in vivo. © 2010 Elsevier B.V.</description>
    </item> <item>
      <title>Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis (Article)</title>
      <link>http://repub.eur.nl/res/pub/24107/</link>
      <pubDate>2009-03-01T00:00:00Z</pubDate>
      <description>Despite lack of classical lymphatic vessels in the central nervous system (CNS), cells and antigens do reach the CNS-draining lymph nodes. These lymph nodes are specialized to mediate mucosal immune tolerance, but can also generate T- and B-cell immunity. Their role in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) therefore remains elusive. We hypothesized that drainage of CNS antigens to the CNS-draining lymph nodes is vital for the recurrent episodes of CNS inflammation. To test this, we surgically removed the superficial cervical lymph nodes, deep cervical lymph nodes, and the lumbar lymph nodes prior to disease induction in three mouse EAE models, representing acute, chronic, and chronic-relapsing EAE. Excision of the CNS-draining lymph nodes in chronic-relapsing EAE reduced and delayed the relapse burden and EAE pathology within the spinal cord, which suggests initiation of CNS antigen-specific immune responses within the CNS-draining lymph nodes. Indeed, superficial cervical lymph nodes from EAE-affected mice demonstrated proliferation against the immunizing peptide, and the deep cervical lymph nodes, lumbar lymph nodes, and spleen demonstrated additional proliferation against other myelin antigen epitopes. This indicates that intermolecular epitope spreading occurs and that CNS antigen-specific immune responses are differentially generated within the different CNS-draining lymphoid organs. Proliferation of splenocytes from lymphadenectomized and sham-operated mice against the immunizing peptide was similar. These data suggest a role for CNS-draining lymph nodes in the induction of detrimental immune responses in EAE relapses, and conclusively demonstrate that the tolerance-inducing capability of cervical lymph nodes is not involved in EAE. Copyright </description>
    </item> <item>
      <title>Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE (Article)</title>
      <link>http://repub.eur.nl/res/pub/24143/</link>
      <pubDate>2009-03-01T00:00:00Z</pubDate>
      <description>Drainage of central nervous system (CNS) antigens to the brain-draining cervical lymph nodes (CLN) is likely crucial in the initiation and control of autoimmune responses during multiple sclerosis (MS). We demonstrate neuronal antigens within CLN of MS patients. In monkeys and mice with experimental autoimmune encephalomyelitis (EAE) and in mouse models with non-inflammatory CNS damage, the type and extent of CNS damage was associated with the frequencies of CNS antigens within the cervical lymph nodes. In addition, CNS antigens drained to the spinal-cord-draining lumbar lymph nodes. In human MS CLN, neuronal antigens were present in pro-inflammatory antigen-presenting cells (APC), whereas the majority of myelin-containing cells were anti-inflammatory. This may reflect a different origin of the cells or different drainage mechanisms. Indeed, neuronal antigen-containing cells in human CLN did not express the lymph node homing receptor CCR7, whereas myelin antigen-containing cells in situ and in vitro did. Nevertheless, CLN from EAE-affected CCR7-deficient mice contained equal amounts of myelin and neuronal antigens as wild-type mice. We conclude that the type and frequencies of CNS antigens within the CLN are determined by the type and extent of CNS damage. Furthermore, the presence of myelin and neuronal antigens in functionally distinct APC populations within MS CLN suggests that differential immune responses can be evoked. </description>
    </item> <item>
      <title>Immunological Function of Draining Lymph Nodes in Multiple Sclerosis and Animal Models
Multiple Sclerosis and Animal Models (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/37557/</link>
      <pubDate>2009-02-04T00:00:00Z</pubDate>
      <description>Multiple sclerosis (MS) is characterized by demyelination and irreversible neuronal damage. Although the cause of this damage is not yet elucidated, autoreactive lymphocytes against myelin and neuronal antigens could be instrumental. In view of understanding MS pathogenesis and possible therapeutic interventions aiming to limit activation of autoreactive lymphocytes, it is crucial to know in what anatomical locations these lymphocytes are activated. We hypothesized that antigens from the central nervous system (CNS) drain to the CNS-draining lymph nodes, and that at this location autoreactive lymphocytes are activated, thereby contributing to infammation during MS and its animal model EAE. To test this hypothesis, we combined analysis of human MS lymph nodes with functional studies using distinct animal models for brain infammation and injury. In this thesis, the involvement of the distinct CNS-draining lymphoid organs in drainage of CNS antigens and immunity against these antigens during MS and EAE will be discussed.</description>
    </item> <item>
      <title>Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology (Article)</title>
      <link>http://repub.eur.nl/res/pub/28864/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description>The zinc-finger transcription factor GATA3 serves as a master regulator of T-helper-2 (Th2) differentiation by inducing expression of the Th2 cytokines IL-4, IL-5 and IL-13 and by suppressing Th1 development. Here, we investigated how GATA3 affects Th17 differentiation, using transgenic mice with enforced GATA3 expression. We activated naïve primary T cells in vitro in the presence of transforming growth factor-β and IL-6, and found that enforced GATA3 expression induced co-expression of Th2 cytokines in IL-17-producing T cells. Although the presence of IL-4 hampered Th17 differentiation, transforming growth factor-β/IL-6 cultures from GATA3 transgenic mice contained substantial numbers of IL-17 cells, partially because GATA3 supported Th17 differentiation by limiting IL-2 and IFN-γ production. GATA3 additionally constrained Th17 differentiation in vitro through IL-4-independent mechanisms, involving downregulating transcription of STAT3, STAT4, NFATc2 and the nuclear factor RORγt, which is crucial for Th17 differentiation. Remarkably, upon myelin oligodendrocyte glycoprotein immunization in vivo, GATA3 transgenic mice contained similar numbers of IL-17-producing T cells in their lymph nodes as wild-type mice, but were not susceptible to autoimmune encephalomyelitis, possibly due to concomitant production of IL-4 and IL-10 induction. We therefore conclude that although GATA3 allows Th17 differentiation, it acts as an inhibitor of Th17-mediated pathology, through IL-4-dependent and IL-4-independent pathways. </description>
    </item> <item>
      <title>Tolerogenic effect of fiber tract injury: Reduced EAE severity following entorhinal cortex lesion (Article)</title>
      <link>http://repub.eur.nl/res/pub/35496/</link>
      <pubDate>2007-04-01T00:00:00Z</pubDate>
      <description>Despite transient, myelin-directed adaptive immune responses in regions of fiber tract degeneration, none of the current models of fiber tract injuries evokes disseminated demyelination, implying effective mechanisms maintaining or re-establishing immune tolerance. In fact, we have recently detected CD95L upregulation accompanied by apoptosis of leukocytes in zones of axonal degeneration induced by entorhinal cortex lesion (ECL), a model of layer-specific axonal degeneration. Moreover, infiltrating monocytes readily transformed into ramified microglia exhibiting a phenotype of immature (CD86+/CD80-) antigen-presenting cells. We now report the appearance of the axonal antigen neurofilament-light along with increased T cell apoptosis and enhanced expression of the pro-apoptotic gene Bad in cervical lymph nodes after ECL. In order to test the functional significance of such local and systemic depletory/regulatory mechanisms on subsequent immunity to central nervous system antigens, experimental autoimmune encephalomyelitis was induced by proteolipid protein immunization 30 days after ECL. In three independent experiments, we found significantly diminished disease scores and infiltrates in lesioned compared to sham-operated SJL mice. This is consistent with a previous meta-statistical analysis (Goodin et al. in Neurology 52:1737-1745, 1999) rejecting the O-hypothesis that brain trauma causes or exacerbates multiple sclerosis. Conversely, brain injuries may involve long-term tolerogenic effects towards brain antigens. </description>
    </item>
  </channel>
</rss>